echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Clin Gastroenterology H: Ear nerve stimulation can improve clinical symptoms in adolescents with irritating bowel syndrome.

    Clin Gastroenterology H: Ear nerve stimulation can improve clinical symptoms in adolescents with irritating bowel syndrome.

    • Last Update: 2020-08-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Ear neurostim stimulation therapy, a non-invasive neurostimation therapy that transmits mesothyli-electric neuromassion (PENFS) to the outer ear, is effective in children with functional abdominal pain disorders.
    preclinical studies have shown that PENFS can reduce visceral pain allergy by regulating the central pain pathway.
    therefore, this study aims to assess the efficacy of PENFS in adolescents with irrita irritatative bowel syndrome (IBS).
    The researchers randomly assigned patients with IBS to a group receiving PENFS for electrostim stimulation therapy (n - 27; middle age: 15.3 years old) or false stimulation (n - 23; middle age, 15.6 years) for a total of 4 weeks five days a week.
    end point was a 30 percent or more reduction in the severity of abdominal pain after 3 weeks.
    secondary endpoint is a symptom relief scale after 3 weeks, which reduces the severity of abdominal pain and improves the overall symptoms.
    , 59 percent of patients who received PENFS had a 30 percent or more reduction in abdominal pain, while 26 percent of patients who received false stimulation had reduced abdominal pain (P .024).
    the median overall pain in patients receiving PENFS was 7.5 (IQR, 3.6-14.4), while the fake surgical group was 14.4 (IQR, 4.5-39.2) (P .026).
    : Ear nerve stimulation reduced abdominal pain ear nerve stimulation in IBS patients lowered abdominal pain scores and improved overall health in IBS adolescents.
    PENFS can be a non-invasive treatment option for pediatric patients with functional bowel disease.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.